- Country: USA
- Summary: CDI Laboratories HuProt v4.0 Human Proteome Microarrays (100) with Biospecimen Screening Service and Analysis
- UST Ref No: 115930413
- Deadline: 11 Mar 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 75N95025Q00167
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
(1) This is a combined synopsis/solicitation for commercial products and/or commercial services prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
(2) The solicitation number is 75N95025Q00167 and the solicitation is issued as a request for quotation (RFQ).
This acquisition is for a commercial product and commercial services and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; and FAR Part 12—Acquisition of Commercial Products and Commercial Services, and is not expected to exceed the simplified acquisition threshold.
THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL AND OPEN COMPETITION (INCLUDING BRAND-NAME).
The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Institute of Mental Health (NIMH), intends to negotiate and award a purchase order without providing for full and open competition (including brand name) to CDI Laboratories Inc., 12 Oeste Calle Mandez Vigo, Mayaguez, PR 00680-4983 for HuProt™ v4.0 Human Proteome Microarrays with Biospecimen Screening Service and Analysis.
This acquisition is conducted as non-competitive for a commercial product or commercial service and is conducted pursuant to FAR 13.106-1(b)(1).
(3) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) Number 2025-03, with effective date January 17, 2025.
(4) The associated NAICS code is 541380 and the small business size standard is $19 million.
(5) This requirement is for the following: HuProt™ v4.0 Human Proteome Micr... - Documents:
Attachment-Invoicing-Provisions-and-Instructions-W.pdf
Purchase-Description_HuProt-Microarray-with-Servic.pdf
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINCDI Laboratories HuProt v4.0 Human Proteome Microarrays (100) with Biospecimen Screening Service and Analysis - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for CDI Laboratories HuProt v4.0 Human Proteome Microarrays (100) with Biospecimen Screening Service and Analysis. This tender is published on USARFP under UST Ref No: 115930413 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-03-11.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
